http://rdf.ncbi.nlm.nih.gov/pubchem/reference/35267790

Outgoing Links

Predicate Object
contentType Journal Article
issn 0014-2999
pageRange 175235-
publicationName European Journal of Pharmacology
startingPage 175235
bibliographicCitation Zhu M, Niu Q, Zhang J, Yu Y, Wang H, Zhu T, Wang G, Yang L, Yin Y, Li P. Amorphous selenium nanodots alleviate non-alcoholic fatty liver disease via activating VEGF receptor 1 to further inhibit phosphorylation of JNK/p38 MAPK pathways. Eur J Pharmacol. 2022 Oct 15;932():175235. doi: 10.1016/j.ejphar.2022.175235. PMID: 36049560.
creator http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a62c730a6a5178cef47ab4eade4877c8
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_637a5b8ec7e5b5d8fa3d9e2a78dc94bb
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f749cfdca0d90dd1b6d4e4932dc98ecc
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_977e3753523f05d37bfe901bd43c35b6
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d3c46e571cee08e1709124d6df378bd9
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_aefc06bfc975a68817b721a527dbff15
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c4349aa990c267be9ffb4cb4352a026a
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_82978b5fd2d73698d714353570c11242
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_bdfe94454eeafd2f03def1c88049dfba
http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0003-2030-1807
date 2022-10-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier https://pubmed.ncbi.nlm.nih.gov/36049560
https://doi.org/10.1016/j.ejphar.2022.175235
isPartOf https://portal.issn.org/resource/ISSN/0014-2999
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/3614
language English
source https://pubmed.ncbi.nlm.nih.gov/
https://www.crossref.org/
title Amorphous selenium nanodots alleviate non-alcoholic fatty liver disease via activating VEGF receptor 1 to further inhibit phosphorylation of JNK/p38 MAPK pathways
discusses http://id.nlm.nih.gov/mesh/M0000972
http://id.nlm.nih.gov/mesh/M0356369
http://id.nlm.nih.gov/mesh/M0019604
http://id.nlm.nih.gov/mesh/M0012553
http://id.nlm.nih.gov/mesh/M0175703
http://id.nlm.nih.gov/mesh/M0234432
hasPrimarySubjectTerm http://id.nlm.nih.gov/mesh/D012643Q000494
http://id.nlm.nih.gov/mesh/D065626Q000378
http://id.nlm.nih.gov/mesh/D012643Q000378
hasSubjectTerm http://id.nlm.nih.gov/mesh/D059305Q000009
http://id.nlm.nih.gov/mesh/D048051Q000378
http://id.nlm.nih.gov/mesh/D040281Q000378
http://id.nlm.nih.gov/mesh/D042461Q000378
http://id.nlm.nih.gov/mesh/D000818
http://id.nlm.nih.gov/mesh/D015398Q000502
http://id.nlm.nih.gov/mesh/D010766
http://id.nlm.nih.gov/mesh/D000637Q000378
http://id.nlm.nih.gov/mesh/D008055
http://id.nlm.nih.gov/mesh/D051381
http://id.nlm.nih.gov/mesh/D008099
discussesAsDerivedByTextMining http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_16f786c43836ae45aa93a433dec9ccf7
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8173
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_4364cf21c8950e29e0eef7c8157371bc
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_07edfd5399a4297179b0eb6e7ec0142a
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6326970
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID11475
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7708

Total number of triples: 52.